Tadashi Kitahara Selected Research

Meniere Disease (Menieres Disease)

2/2021	Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research.
1/2021	Endolymphatic Sac Drainage Surgery and Plasma Stress Hormone Vasopressin Levels in Meniere's Disease.
2/2020	Results in caloric test, video head impulse test and inner ear MRI in patients with Ménière's disease.
4/2019	Ménière's disease with unremitting floating sensation is associated with canal paresis, gravity-sensitive dysfunction, mental illness, and bilaterality.
1/2019	Three-Dimensional Magnetic Resonance Imaging Reveals the Relationship Between the Control of Vertigo and Decreases in Endolymphatic Hydrops After Endolymphatic Sac Drainage With Steroids for Meniere's Disease.
8/2018	A high jugular bulb and poor development of perivestibular aqueductal air cells are not the cause of endolymphatic hydrops in patients with Ménière's disease.
3/2017	Assessment of endolymphatic hydrops and otolith function in patients with Ménière's disease.
2/2017	Identification of operculum and surgical results in endolymphatic sac drainage surgery.
6/2016	Surgical results and psychological status in patients with intractable Ménière's disease.
1/2016	A Two-Year Randomized Trial of Interventions to Decrease Stress Hormone Vasopressin Production in Patients with Meniere's Disease-A Pilot Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadashi Kitahara Research Topics

Disease

25	Meniere Disease (Menieres Disease) 02/2021 - 05/2002
15	Endolymphatic Hydrops 04/2022 - 04/2009
14	Vertigo (Positional Vertigo) 08/2022 - 05/2002
9	Dizziness (Lightheadedness) 08/2022 - 04/2003
8	Neoplasms (Cancer) 07/2019 - 07/2006
6	Hearing Loss (Hearing Impairment) 10/2020 - 09/2006
5	Otitis Media 01/2021 - 06/2009
5	Edema (Dropsy) 03/2017 - 09/2011
4	Sensorineural Hearing Loss 01/2021 - 01/2014
4	Paresis (Hemiparesis) 04/2019 - 04/2003
4	Ganglion Cysts (Ganglion) 04/2014 - 10/2005
3	Tinnitus 04/2022 - 10/2020
3	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2019
2	Pathologic Constriction (Stenosis) 07/2022 - 05/2002
2	Paralysis (Palsy) 04/2021 - 07/2006
2	Squamous Cell Carcinoma of Head and Neck 07/2019 - 10/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016 - 04/2005
2	Mental Disorders (Mental Disorder) 01/2016 - 01/2007
2	Cholesteatoma 07/2014 - 02/2012
2	Motion Sickness (Airsickness) 01/2012 - 10/2003
2	Pica (Geophagia) 01/2012 - 10/2003
1	Orthostatic Hypotension (Postural Hypotension) 08/2022
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2022
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Conductive Hearing Loss 12/2021
1	Anaplastic Thyroid Carcinoma 08/2021
1	Sleep Wake Disorders 01/2021
1	Deafness (Deaf Mutism) 01/2021
1	Disease Progression 01/2019
1	Adenocarcinoma 01/2019
1	Hematuria 04/2015
1	Tonsillitis 04/2015
1	Hypertrophy 04/2015
1	Fistula 07/2014
1	Lipoma (Lipomata) 01/2014
1	Esophageal Neoplasms (Esophageal Cancer) 11/2013
1	Vomiting 01/2012

Drug/Important Bio-Agent (IBA)

14	SteroidsIBA 01/2021 - 05/2002
11	GadoliniumIBA 04/2022 - 06/2011
8	Vasopressins (Vasopressin)IBA 01/2021 - 05/2002
6	Messenger RNA (mRNA)IBA 10/2016 - 11/2007
3	Hormones (Hormone)IBA 01/2021 - 01/2007
3	Glycerol (Glycerine)FDA LinkGeneric 09/2020 - 08/2013
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016 - 07/2004
2	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 11/2016
2	ResveratrolIBA 07/2019 - 10/2016
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016 - 01/2007
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2014 - 01/2014
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 09/2011 - 09/2009
1	hydroxide ionIBA 08/2022
1	SalicylatesIBA 04/2022
1	gosha-jinki-ganIBA 04/2022
1	Sodium Salicylate (Salicylate, Sodium)IBA 04/2022
1	A 19IBA 01/2022
1	Codon (Codons)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 09/2021
1	lenvatinibIBA 08/2021
1	DiureticsIBA 02/2021
1	Arginine Vasopressin (Argipressin)IBA 01/2021
1	Explosive Agents (Explosives)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 07/2019
1	PotassiumIBA 01/2019
1	alectinibIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	CrizotinibIBA 01/2019
1	Histone Deacetylase InhibitorsIBA 10/2016
1	PolyphenolsIBA 10/2016
1	ThiazolidinedionesIBA 10/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2016
1	CytokinesIBA 10/2016
1	Milnacipran (Ixel)FDA Link 01/2016
1	Interleukin-12 (IL 12)IBA 04/2015
1	A-factor (Streptomyces)IBA 10/2014
1	Coloring Agents (Dyes)IBA 09/2013
1	AMP-Activated Protein KinasesIBA 03/2012
1	beta Adrenergic ReceptorsIBA 03/2012
1	N 30IBA 02/2012

Therapy/Procedure

13	Therapeutics 08/2021 - 04/2003
4	Hearing Aids (Hearing Aid) 12/2021 - 01/2018
4	Mastoidectomy 01/2021 - 07/2006
4	Decompression 12/2014 - 04/2011
3	Tympanoplasty 07/2014 - 06/2009
2	Radiotherapy 07/2022 - 04/2005
2	Tonsillectomy 04/2015 - 07/2011
2	Chemoradiotherapy 11/2013 - 05/2002
2	Aftercare (After-Treatment) 01/2007 - 05/2004
2	Denervation 09/2006 - 10/2005
1	Lymph Node Excision (Lymph Node Dissection) 07/2022
1	Palliative Care (Palliative Therapy) 04/2022
1	Intraperitoneal Injections 04/2022
1	Intravenous Injections 04/2022
1	Thyroidectomy 01/2022
1	Free Tissue Flaps 08/2021
1	Laryngoplasty 04/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Reoperation 07/2015
1	Tracheotomy 01/2014
1	Surgical Instruments (Clip) 01/2014
1	Esophagectomy 11/2013